549 related articles for article (PubMed ID: 33758031)
21. Gut microbiome-based supervised machine learning for clinical diagnosis of inflammatory bowel diseases.
Manandhar I; Alimadadi A; Aryal S; Munroe PB; Joe B; Cheng X
Am J Physiol Gastrointest Liver Physiol; 2021 Mar; 320(3):G328-G337. PubMed ID: 33439104
[TBL] [Abstract][Full Text] [Related]
22. Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease Course.
Catalán-Serra I; Thorsvik S; Beisvag V; Bruland T; Underhill D; Sandvik AK; Granlund AVB
Inflamm Bowel Dis; 2023 Dec; ():. PubMed ID: 38103028
[TBL] [Abstract][Full Text] [Related]
23. Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.
Walkiewicz D; Werlin SL; Fish D; Scanlon M; Hanaway P; Kugathasan S
Inflamm Bowel Dis; 2008 May; 14(5):669-73. PubMed ID: 18240279
[TBL] [Abstract][Full Text] [Related]
24. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
[TBL] [Abstract][Full Text] [Related]
25. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
[TBL] [Abstract][Full Text] [Related]
26. Fecal Zonulin as a Noninvasive Biomarker of Intestinal Permeability in Pediatric Patients with Inflammatory Bowel Diseases-Correlation with Disease Activity and Fecal Calprotectin.
Szymanska E; Wierzbicka A; Dadalski M; Kierkus J
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501351
[TBL] [Abstract][Full Text] [Related]
27. Potential Oral Microbial Markers for Differential Diagnosis of Crohn's Disease and Ulcerative Colitis Using Machine Learning Models.
Kang SB; Kim H; Kim S; Kim J; Park SK; Lee CW; Kim KO; Seo GS; Kim MS; Cha JM; Koo JS; Park DI
Microorganisms; 2023 Jun; 11(7):. PubMed ID: 37512838
[TBL] [Abstract][Full Text] [Related]
28. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
[TBL] [Abstract][Full Text] [Related]
29. Specificities of the fecal microbiota in inflammatory bowel disease.
Sokol H; Seksik P; Rigottier-Gois L; Lay C; Lepage P; Podglajen I; Marteau P; Doré J
Inflamm Bowel Dis; 2006 Feb; 12(2):106-11. PubMed ID: 16432374
[TBL] [Abstract][Full Text] [Related]
30. Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease.
Ashorn S; Honkanen T; Kolho KL; Ashorn M; Välineva T; Wei B; Braun J; Rantala I; Luukkaala T; Iltanen S
Inflamm Bowel Dis; 2009 Feb; 15(2):199-205. PubMed ID: 18618670
[TBL] [Abstract][Full Text] [Related]
31. A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients.
Jacobs JP; Goudarzi M; Singh N; Tong M; McHardy IH; Ruegger P; Asadourian M; Moon BH; Ayson A; Borneman J; McGovern DP; Fornace AJ; Braun J; Dubinsky M
Cell Mol Gastroenterol Hepatol; 2016 Nov; 2(6):750-766. PubMed ID: 28174747
[TBL] [Abstract][Full Text] [Related]
32. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
33. Location-specific signatures of Crohn's disease at a multi-omics scale.
Gonzalez CG; Mills RH; Zhu Q; Sauceda C; Knight R; Dulai PS; Gonzalez DJ
Microbiome; 2022 Aug; 10(1):133. PubMed ID: 35999575
[TBL] [Abstract][Full Text] [Related]
34. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
35. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
36. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
[TBL] [Abstract][Full Text] [Related]
37. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease.
Tibble JA; Sigthorsson G; Bridger S; Fagerhol MK; Bjarnason I
Gastroenterology; 2000 Jul; 119(1):15-22. PubMed ID: 10889150
[TBL] [Abstract][Full Text] [Related]
38. Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease.
Liu F; Lee SA; Riordan SM; Zhang L; Zhu L
Front Med (Lausanne); 2020; 7():580803. PubMed ID: 33392214
[TBL] [Abstract][Full Text] [Related]
39. The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases.
Farkas K; Saródi Z; Bálint A; Földesi I; Tiszlavicz L; Szűcs M; Nyári T; Tajti J; Nagy F; Szepes Z; Bor R; Annaházi A; Róka R; Molnár T
J Crohns Colitis; 2015 Mar; 9(3):231-7. PubMed ID: 25585596
[TBL] [Abstract][Full Text] [Related]
40. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
